(Q35971398)

11 August 2017

1 reference

title

Exotic emerging viral diseases: progress and challenges (English)

1 reference

11 August 2017

1

Thomas W Geisbert

1 reference

11 August 2017

2

Peter B Jahrling

1 reference

PubMed ID

15577929

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

11 August 2017

1 reference

11 August 2017

10

1 reference

11 August 2017

S110-21

1 reference

11 August 2017

12 Suppl

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1142

11 August 2017

0 references

cites work

Evaluation in nonhuman primates of vaccines against Ebola virus

1 reference

Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever

21 January 2018

1 reference

Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management

21 January 2018

1 reference

Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola).

21 January 2018

1 reference

Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection

21 January 2018

1 reference

Ultrastructural and Immunohistochemical Studies in Five Cases of Argentine Hemorrhagic Fever

21 January 2018

1 reference

Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin

21 January 2018

1 reference

Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States

21 January 2018

1 reference

Outbreak of jaundice and hemorrhagic fever in the Southeast of Brazil in 2001: detection and molecular characterization of yellow fever virus

21 January 2018

1 reference

Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells

21 January 2018

1 reference

Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses

21 January 2018

1 reference

C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans

21 January 2018

1 reference

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

21 January 2018

1 reference

DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

21 January 2018

1 reference

Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry

21 January 2018

1 reference

Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus

21 January 2018

1 reference

New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor

21 January 2018

1 reference

The viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor

21 January 2018

1 reference

Clinical Pathology of Yellow Fever

21 January 2018

1 reference

Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain

21 January 2018

1 reference

Monitoring of clinical and laboratory data in two cases of imported Lassa fever

21 January 2018

1 reference

Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy

21 January 2018

1 reference

Marburg agent disease: pathology.

21 January 2018

1 reference

The pathology of Lassa fever

21 January 2018

1 reference

Marburg agent disease: In monkeys

21 January 2018

1 reference

A Rhesus Monkey Model for the Study of Bolivian Hemorrhagic Fever

21 January 2018

1 reference

Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels

21 January 2018

1 reference

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

21 January 2018

1 reference

Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily

21 January 2018

1 reference

Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses

21 January 2018

1 reference

Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells

21 January 2018

1 reference

The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses

21 January 2018

1 reference

The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins

21 January 2018

1 reference

Endogenous Interferon in Argentine Hemorrhagic Fever

21 January 2018

1 reference

Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever

21 January 2018

1 reference

Immune and pathophysiological processes in baboons experimentally infected with Ebola virus adapted to guinea pigs

21 January 2018

1 reference

Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever

21 January 2018

1 reference

Activation of the cytokine network and unfavorable outcome in patients with yellow fever

21 January 2018

1 reference

Infection and activation of monocytes by Marburg and Ebola viruses

21 January 2018

1 reference

Endothelial cell function alteration after Junin virus infection.

21 January 2018

1 reference

Human asymptomatic Ebola infection and strong inflammatory response

21 January 2018

1 reference

Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus

21 January 2018

1 reference

Are all type I human interferons equivalent?

21 January 2018

1 reference

The Ebola virus VP35 protein functions as a type I IFN antagonist.

21 January 2018

1 reference

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

21 January 2018

1 reference

Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs

21 January 2018

1 reference

Nitric oxide in the pathogenesis of vascular disease

21 January 2018

1 reference

Ebola haemorrhagic fever: experimental infection of monkeys

21 January 2018

1 reference

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys

21 January 2018

1 reference

Coagulation studies in Argentine hemorrhagic fever

21 January 2018

1 reference

Venezuelan haemorrhagic fever

21 January 2018

1 reference

Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event

21 January 2018

1 reference

Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity

21 January 2018

1 reference

Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity

21 January 2018

1 reference

Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture

21 January 2018

1 reference

Reverse Genetics for Crimean-Congo Hemorrhagic Fever Virus

21 January 2018

1 reference

A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication

21 January 2018

1 reference

The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model

21 January 2018

1 reference

Laser capture microdissection

21 January 2018

1 reference

Laser capture microdissection: molecular analysis of tissue

21 January 2018

1 reference

21 January 2018

Yellow fever: an update

1 reference

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.

21 January 2018

1 reference

Effective vaccine for lassa fever

21 January 2018

1 reference

Development of a preventive vaccine for Ebola virus infection in primates

21 January 2018

1 reference

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

21 January 2018

1 reference

Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification

21 January 2018

1 reference

In-vivo activity of antivirals against exotic RNA viral infections

21 January 2018

1 reference

Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug

21 January 2018

1 reference

Crimean Congo-haemorrhagic fever treated with oral ribavirin

21 January 2018

1 reference

Treatment of Bolivian hemorrhagic fever with intravenous ribavirin.

21 January 2018

1 reference

The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran

21 January 2018

1 reference

Recombinant Human Interferon-γ Modulates Rift Valley Fever Virus Infection in the Rhesus Monkey

21 January 2018

1 reference

Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome

21 January 2018

1 reference

Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma

21 January 2018

1 reference

The use of Lassa fever convalescent plasma in Nigeria

21 January 2018

1 reference

Lassa fever A study of 23 hospital cases

21 January 2018

1 reference

Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization

21 January 2018

1 reference

Inhibition of influenza virus production in virus-infected mice by RNA interference

21 January 2018

1 reference

Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice

21 January 2018

1 reference

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

21 January 2018

1 reference

Human fatal yellow fever. Immunohistochemical detection of viral antigens in the liver, kidney and heart

21 January 2018

1 reference

Major Expansion of γδ T Lymphocytes following Cytomegalovirus Infection in Kidney Allograft Recipients

21 January 2018

1 reference

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit

21 January 2018

1 reference

7 January 2021

Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response

1 reference

7 January 2021

Virus-specific factors in experimental Argentine hemorrhagic fever in rhesus macaques

1 reference

7 January 2021

Pathogenesis and pathophysiology of yellow fever

1 reference

7 January 2021

Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy

1 reference

7 January 2021

The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus

1 reference

7 January 2021

Outbreake of Marburg virus disease in Johannesburg.

1 reference

7 January 2021

Pathology of Lassa virus infection in the rhesus monkey.

1 reference

7 January 2021

Experimental Argentine hemorrhagic fever in rhesus macaques: virus-specific variations in pathology

1 reference

7 January 2021

Experimental Rift Valley fever in rhesus macaques

1 reference

7 January 2021

Hematologic dysfunction in Lassa fever

1 reference

7 January 2021

Pathology of Bolivian Hemorrhagic Fever in the African Green Monkey

1 reference

7 January 2021

Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues

1 reference

7 January 2021

Congo-Crimean haemorrhagic fever in Dubai: histopathological studies

1 reference

7 January 2021

Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene

1 reference

7 January 2021

Lymphocyte subsets alteration in patients with argentine hemorrhagic fever

1 reference

7 January 2021

Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses

1 reference

7 January 2021

Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques

1 reference

7 January 2021

Nitric oxide induces a decrease in the mitochondrial membrane potential of peripheral blood lymphocytes, especially in natural killer cells

1 reference

7 January 2021

Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy

1 reference

7 January 2021

High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

1 reference

7 January 2021

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity

1 reference

7 January 2021

Increased tumor necrosis factor-alpha levels in Argentine hemorrhagic fever

1 reference

7 January 2021

Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever

1 reference

7 January 2021

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection

1 reference

7 January 2021

Current understanding of disseminated intravascular coagulation

1 reference

7 January 2021

Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients

1 reference

7 January 2021

The original haemorrhagic fever: yellow fever

1 reference

7 January 2021

Alteration of blood coagulation and complement system in neotropical primates infected with Junin virus

1 reference

7 January 2021

Kinetic study of platelets and fibrinogen in Lassa virus-infected monkeys and early pathologic events in Mopeia virus-infected monkeys

1 reference

7 January 2021

Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group

1 reference

7 January 2021

Towards a vaccine against Ebola virus

1 reference

7 January 2021

1 reference

7 January 2021

Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model

1 reference

7 January 2021

Lassa fever. Effective therapy with ribavirin

1 reference

7 January 2021

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

1 reference

7 January 2021

Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha.

1 reference

7 January 2021

Lassa fever, a new virus disease of man from West Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease

1 reference

7 January 2021

A case of Ebola virus infection

1 reference

7 January 2021

Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee

1 reference

7 January 2021

Antibody response in Crimean-Congo hemorrhagic fever

1 reference

7 January 2021

Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages?

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1142

1 reference

11 August 2017

1 reference

PubMed ID

15577929